Trial record 1 of 1 for:    HPP854
Previous Study | Return to List | Next Study

Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease

This study has been terminated.
Information provided by (Responsible Party):
High Point Pharmaceuticals, LLC. Identifier:
First received: November 10, 2011
Last updated: August 29, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)